Study Reveals Public Perceptions and Challenges of Innovation in 10 Countries

Jan.24.2025
Study Reveals Public Perceptions and Challenges of Innovation in 10 Countries
PMI's independent survey shows most believe innovation can address key issues, but hurdles like misinformation and outdated policies exist.

On January 22nd, Philip Morris International (PMI) announced on its official website that an independent investigation commissioned by the company and conducted by Povaddo in 10 countries across Africa, the Americas, Asia, and Europe, revealed in a white paper titled "Innovation Under Pressure: Harnessing Complexity to Drive Change" that the majority of people believe innovation has the potential to address key issues in the next 10 to 20 years.


The survey results indicate that innovation faces many challenges in driving social change, including misleading information, outdated biases, and policymakers struggling to keep pace with rapid technological advancements. About 80% of respondents believe that misleading information weakens the application of crucial innovations, while 90% of respondents agree that it is crucial for the government to ensure that the public has access to accurate innovation information and to establish clear and fair regulatory measures.


A survey showed that approximately three-quarters (71%) of respondents believe that disruptive innovation can promote the development and deployment of vaccines, while nearly two-thirds (62%) believe that innovation can ensure everyone has access to high-quality and affordable healthcare services. However, there is a significant divergence of opinion on whether innovation can reduce smoking rates (49%) and illegal drug use (43%), reflecting the complexity and stubbornness of these issues.


While the public is optimistic about the opportunities brought by technology and innovation in the coming years (76% agree), the majority of people (74%) also agree that discussions around new innovations have become polarized, leading to consumer confusion. Furthermore, in these 10 countries, eight in ten citizens believe that misleading information is hindering progress.


The CEO of PMI, Jacek Olczak, stated that the company is committed to creating healthier alternatives to cigarettes through scientific and technological innovation, with a focus on global public health. However, the progress of innovation is often hindered by misunderstandings. Olczak emphasized that before dismissing the possibility of innovation, especially policymakers, should take the time to review scientific and public health evidence and make decisions based on facts rather than outdated assumptions.


The evidence supporting smoke-free alternatives to cigarettes is increasing, as seen in countries like Sweden with the lowest smoking rates in Europe, or Japan where smoking rates have decreased by 45% since introducing heated tobacco products in 2014. In other industries, accepting such innovation and allowing it to replace more harmful products is considered common sense. A small minority of opponents should not hinder the progress of around 1 billion adult smokers worldwide and public health.


Roughly two-thirds of survey participants (64%) are concerned that the pace of technological change is too fast for society and the economy to adapt. Respondents also pointed out a lack of information about the pros and cons of these innovations, public skepticism and distrust (often driven by social media), and thorny ethical issues. The public is looking to the government to take action and accelerate the adoption of advancements that can have a positive impact. The vast majority (90%) of respondents believe that it is very important for the government to ensure that the public has access to accurate information and establish clear and fair regulations. In addition, 87% emphasized the government's responsibility to address the challenge of misleading information, 83% highlighted the importance of public-private sector collaboration, and 82% believed it is necessary to promote open and balanced public debate on emerging innovations.


PMI calls on governments, public health institutions, and civil society to embrace proactive change and engage in constructive dialogue based on science and evidence.


The methodology of this survey is based on an international survey conducted by Povaddo from December 13th to 27th, 2024. The survey included 10,250 ordinary citizens aged 21 and above in 10 countries: Argentina, Brazil, France, Italy, Mexico, South Africa, South Korea, Spain, the United Kingdom, and the United States. The overall margin of error for the survey results is ±1%.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
As cigarette volumes continue to decline, U.S. convenience-store operators are reconfiguring backbar space to accommodate modern oral nicotine products such as nicotine pouches. Industry data show nicotine pouches have become one of the fastest-growing nicotine categories while generating higher margins for retailers.
Jun.12
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Vapesourcing has listed RELX Creator Pro 15K as “Coming Soon” with U.S. warehouse shipping options; while the page does not show that RELX has entered the U.S. market through official channels or that the product has received FDA authorization, the listing suggests that Chinese brand-led ENDS products are becoming a new point of observation as the U.S. market reassesses regulatory risk following the FDA’s updated enforcement-priority policy.
Industry Insight
Jun.11
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA’s proposed rule requiring foreign tobacco manufacturers to register establishments and list products is more than routine paperwork, Keller and Heckman LLP partner Azim Chowdhury told 2Firsts. He said it could strengthen FDA’s import enforcement, inspections and market surveillance. Chinese e-cigarette OEM/ODM manufacturers, specification developers, brand owners and component suppliers may need to review their roles, product data and U.S. market authorization status.
Special Report
Jun.29
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
China Tobacco International HK Warns First-Half Revenue May Fall 25%-30%, Tobacco Leaf and Duty-Free Exposure Highlight Reliance on Traditional Tobacco
China Tobacco International HK Warns First-Half Revenue May Fall 25%-30%, Tobacco Leaf and Duty-Free Exposure Highlight Reliance on Traditional Tobacco
CTIHK expects first-half 2026 revenue to fall 25%-30%, mainly due to lower tobacco leaf imports and delayed cigarette shipments to China’s domestic duty-free market. Its 2025 revenue mix—nearly 90% from tobacco leaf-related businesses and less than 1% from new tobacco products—shows continued exposure to traditional supply chains and trade variables.
Jun.18